New product [Regulatives / Guidelines]

posted by Ohlbe – France, 2020-03-11 18:54 (1111 d 21:32 ago) – Posting: # 21257
Views: 3,919

Dear SKM,

❝ Both the APIs are registered and marketed as separate formulation. We are mixing these two at same ratio into one formulation without adding any new excipients. I don't know why will it be considered as a new product. Can you guide me please?


Well, you are giving all the arguments yourself: up to now the two active substances are only marketed as separate formulations. You will be mixing them into one new formulation, which has never been tested or marketed before. Sorry, but I can't explain more.

Regards
Ohlbe

Complete thread:

UA Flag
Activity
 Admin contact
22,557 posts in 4,724 threads, 1,607 registered users;
17 visitors (0 registered, 17 guests [including 8 identified bots]).
Forum time: 17:26 CEST (Europe/Vienna)

Science is wonderfully equipped to answer the question “How?”
but it gets terribly confused when you ask the question “Why?”    Erwin Chargaff

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5